Healthcare provider profile · identity verified

Shane S Young, M.D.

Family Practice · WEST HAZLETON, PA · NPI 1861555823

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	428	112
Atorvastatin Calcium	Atorvastatin Calcium	401	112
Omeprazole	Omeprazole	322	91
Lisinopril	Lisinopril	319	85
Levothyroxine Sodium	Levothyroxine Sodium	300	70
Amlodipine Besylate	Amlodipine Besylate	291	77
Duloxetine Hcl	Duloxetine Hcl	241	56
Fluticasone Propionate	Fluticasone Propionate	234	95
Losartan Potassium	Losartan Potassium	166	49
Metformin Hcl Er	Metformin Hcl	158	44
Tamsulosin Hcl	Tamsulosin Hcl	157	39
Metoprolol Succinate	Metoprolol Succinate	146	44
Eliquis	Apixaban	143	33
Jardiance	Empagliflozin	135	27
Albuterol Sulfate Hfa	Albuterol Sulfate	110	50
Gabapentin	Gabapentin	109	25
Metformin Hcl	Metformin Hcl	107	33
Hydrochlorothiazide	Hydrochlorothiazide	104	30
Furosemide	Furosemide	92	26
Pantoprazole Sodium	Pantoprazole Sodium	91	25
Pravastatin Sodium	Pravastatin Sodium	91	27
Metoprolol Tartrate	Metoprolol Tartrate	83	21
Ezetimibe	Ezetimibe	75	24
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	74	74
Allopurinol	Allopurinol	74	18
Simvastatin	Simvastatin	74	17
Clopidogrel	Clopidogrel Bisulfate	69	20
Sertraline Hcl	Sertraline Hcl	69	19
Carvedilol	Carvedilol	67	20
Finasteride	Finasteride	65	16
Ozempic	Semaglutide	60	15
Alendronate Sodium	Alendronate Sodium	59	18
Glipizide Er	Glipizide	59	19
Tradjenta	Linagliptin	58	12
Trazodone Hcl	Trazodone Hcl	58	14
Montelukast Sodium	Montelukast Sodium	53	15
Ibuprofen	Ibuprofen	50	21
Azelastine Hcl	Azelastine Hcl	46	22
Glipizide	Glipizide	45	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	43	suppressed
Chlorthalidone	Chlorthalidone	42	13
Escitalopram Oxalate	Escitalopram Oxalate	40	suppressed
Spironolactone	Spironolactone	39	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	suppressed
Benazepril Hcl	Benazepril Hcl	37	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	29
Atenolol	Atenolol	34	suppressed
Prednisone	Prednisone	33	22
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	12
Xultophy 100-3.6	Insulin Degludec/Liraglutide	33	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	32	suppressed
Doxepin Hcl	Doxepin Hcl	32	suppressed
Trulicity	Dulaglutide	32	suppressed
Alprazolam	Alprazolam	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Nitroglycerin	Nitroglycerin	31	18
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	31	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	30	suppressed
Warfarin Sodium	Warfarin Sodium	30	11
Myrbetriq	Mirabegron	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Meloxicam	Meloxicam	28	suppressed
Famotidine	Famotidine	26	suppressed
Tramadol Hcl	Tramadol Hcl	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Lorazepam	Lorazepam	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	20	16
Enalapril Maleate	Enalapril Maleate	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Unifine Pentips	Pen Needle, Diabetic	19	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	18	suppressed
Baclofen	Baclofen	17	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	17	17
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	15
Cefdinir	Cefdinir	16	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Mometasone Furoate	Mometasone Furoate	16	suppressed
Torsemide	Torsemide	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Naproxen	Naproxen	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	13
Eszopiclone	Eszopiclone	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Ramipril	Ramipril	13	suppressed
Trospium Chloride	Trospium Chloride	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Potassium Chloride	Potassium Chloride	11	suppressed
Repaglinide	Repaglinide	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error